Advertisement

Topics

Otsuka Maryland Research Institute (OMRI) Company Profile

19:40 EDT 23rd September 2017 | BioPortfolio

Otsuka Maryland Research Institute (OMRI) is a leader in the research and clinical development of healthcare products, and is a cornerstone of the global development of Otsuka Pharmaceuticals Company, Inc.

Location

2440 Research Blvd
Rockville
MD
20850
United States of America

Contact

Phone: (301) 990-0030
Fax: (301) 212-8647
Email: debrak@otsuka.com


News Articles [2696 Associated News Articles listed on BioPortfolio]

M&As this week: Otsuka Pharmaceutical Factory, Sygnis

Otsuka Pharmaceutical Factory has signed an agreement to acquire 20% of outstanding shares in Otsuka Pharmaceutical India Private (OPI).

Institute of Food Research Transitions into Quadram Institute Bioscience

The new £multi-million food and health research centre that will become the state-of-the-art home for the Quadram Institute is on schedule to be complete by mid-2018.  As a first step to re...

Otsuka Secures Exclusive Rights In Japan To Fremanezumab

PETAH TIKVA (dpa-AFX) - Otsuka Pharmaceutical Co., Ltd and Teva Pharmaceutical Industries, Ltd. (TEVA) announced an agreement covering Japan for Otsuka to develop and commercialize Teva's investig...

Otsuka, Teva collaborate to develop and commercialise fremanezumab for migraine

Otsuka Pharmaceutical Co and Teva Pharmaceutical Industries, Ltd, have announce an agreement covering Japan for Otsuka to develop and commercialize Teva's investigational drug candidate fremanezumab (...

Bipolar I disorder drug from Otsuka, Lundbeck gets FDA nod

The once-monthly, extended-release injectable Abilify Maintena, or aripiprazole, from Otsuka Pharmaceutical and H.  -More- 

Mylan partners with Otsuka to commercialize tuberculosis med delamanid in high-burden countries

Subsidiaries of Mylan N.V. and Otsuka Pharmaceutical Co. ink an agreement to commercialize delamanid, branded as Deltyba by Otsuka, for the treatment of adults with pulmonary multidrug-resistant tuber...

Otsuka buys Japanese license to Teva's migraine drug

Otsuka is dropping $50 million in a lump sum payment for access to fremanezumab, which is in Phase 3 testing for various headache conditions.

Maryland Soybean Board Seeks Research Proposals

Maryland Soybean Board asks researchers seeking funding from the board to submit a pre-proposal by October 15. SALISBURY, MARYLAND (PRWEB) September 12, 2017 Soybean researchers seeking funding from ...

PubMed Articles [2412 Associated PubMed Articles listed on BioPortfolio]

A History of the Western Institute of Nursing and Its Communicating Nursing Research Conferences.

The Western Institute of Nursing (WIN) celebrated its 60th anniversary and the 50th Annual Communicating Nursing Research Conference in April 2017.

Letter--The Authors Respond.

None of the authors of this study are involved in financial or personal relationships with agencies, institutions, or organizations that inappropriately influenced the statistical analysis plan or int...

Adherence to the World Cancer Research Fund/American Institute for Cancer Research recommendations and colorectal cancer risk.

The World Cancer Research Fund (WCRF) and the American Institute for Cancer Research (AICR) released in 2007 eight recommendations for cancer prevention on body fatness, diet and physical activity. O...

Cell scientist to watch - Paul Timpson.

Paul Timpson received his bachelor's degree from the University of Strathclyde, UK and completed his PhD under the supervision of Margaret Frame at the Beatson Institute for Cancer Research and the Un...

Effect of a Clinical and Translational Science Award institute on grant funding in a major research university.

Previous studies have examined the impact of Clinical and Translational Science Awards programs on other outcomes, but not on grant seeking. The authors examined the effects on grant seeking of the Mi...

Clinical Trials [1471 Associated Clinical Trials listed on BioPortfolio]

Screening Protocol for Research Participants

The Screening Protocol is a system devised to evaluate potential research participants for National Institute on Drug Abuse/Maryland Psychiatric Research Center (NIDA/MPRC) studies.

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Schizophrenia and the Gut Microbiome

In a sample of 20 inpatients with a DSM-IV-TR/DSM 5 diagnosis of schizophrenia or schizoaffective disorder, investigators propose to conduct a prospective, 2 week observational trial to co...

Evaluation and Treatment of People With Eye Diseases

This study will evaluate and provide standard treatments for people with various eye conditions. It will provide a resource for enrollment into new research protocols throughout the Eye In...

Screening Protocol for the Evaluation of Research Participants at the Maryland Psychiatric Research Center (MPRC)

Background: - The National Institute of Drug Abuse (NIDA) is interested in developing a pool of potential research participants who may be eligible for research studies on drug abuse and ...

Companies [2437 Associated Companies listed on BioPortfolio]

Otsuka Maryland Research Institute (OMRI)

Otsuka Maryland Research Institute (OMRI) is a leader in the research and clinical development of healthcare products, and is a cornerstone of the global development of Otsuka Pharmaceuticals Company,...

Otsuka America Pharmaceutical, Inc.

Otsuka America Pharmaceutical, Inc. (OAPI) is a successful, innovative, fast-growing healthcare company that commercializes Otsuka-discovered and other product opportunities in North America, with a s...

Institute of Human Virology (IHV) at the University of Maryland School of Medicine

Formed in 1996 as a partnership between the State of Maryland, the City of Baltimore, the University System of Maryland and the University of Maryland Medical System, IHV is an in...

Institute of Human Virology of The University of Maryland School of Medicine

Formed in 1996 as a partnership between the State of Maryland, the City of Baltimore, the University System of Maryland and the University of Maryland Medical System, IHV is an institute of the Univer...

Otsuka Pharmaceutical Co., Ltd./H. Lundbeck A/S

Otsuka Pharmaceutical is a global healthcare company with the corporate philosophy: “Otsuka – people creating new products for better health worldwide.” Otsuka rese...

More Information about "Otsuka Maryland Research Institute (OMRI)" on BioPortfolio

We have published hundreds of Otsuka Maryland Research Institute (OMRI) news stories on BioPortfolio along with dozens of Otsuka Maryland Research Institute (OMRI) Clinical Trials and PubMed Articles about Otsuka Maryland Research Institute (OMRI) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Otsuka Maryland Research Institute (OMRI) Companies in our database. You can also find out about relevant Otsuka Maryland Research Institute (OMRI) Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...


Corporate Database Quicklinks



Searches Linking to this Company Record